# Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI

> **NCT05486572** · NA · RECRUITING · sponsor: **VA Office of Research and Development** · enrollment: 4700 (estimated)

## Conditions studied

- Carcinoma, Hepatocellular
- Cirrhosis

## Interventions

- **OTHER:** Abbreviated Magnetic Resonance Imaging with serum AFP
- **OTHER:** Abdominal Ultrasound Screening with serum AFP

## Key facts

- **NCT ID:** NCT05486572
- **Lead sponsor:** VA Office of Research and Development
- **Sponsor class:** FED
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-11-03
- **Primary completion:** 2030-09-01
- **Final completion:** 2031-09-01
- **Target enrollment:** 4700 (ESTIMATED)
- **Last updated:** 2026-04-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05486572

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05486572, "Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05486572. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*